Usefulness of Positron Emission Tomography in the Examination of Hilar and Mediastinal Lymphadenopathies in Patients with Suspicion of Lung Cancer

Table 1

Description of the sample: distribution by age, sex, smoking habit, mean nodule size, and characteristics of punctured lymph node stations.

	Age	Nodule size (mm)		SUV; PET	Sex	Lymph node stations						Smoking habit
		CT	EBUS			Punctured		Diagnosis		Method
M	66	14.5	15.5	7	106 MEN (52.5%)	2R	2 (1%)	EC	23 (11.3%)	EBUS	48 (82.8%)	AS	54 (42.2%)
ME	67	11	14	4.7	22 WM (10.8%)	4R	63 (31%)	AC	35 (17.2%)	MT	5 (8.6%)	ES	43 (33.6%)
SD	10.2	8.1	7.8	11.1		4L	34 (16.8%)	MC	18 (8.9%)	S	5 (8.6%)	NS	17 (13.3%)
						7	62 (30.5%)	LPH	1 (0.5%)			ND	14 (10.9%)
						10R	8 (3.9%)	SC	7 (3.4%)
						10L	7 (3.4%)	TB	8 (3.9%)
						11R	16 (7.9%)	NLN	111 (54.7%)
						11L	11 (5.4%)

AC, adenocarcinoma; C, surgery; EC, epidermoid carcinoma; MC, microcytic carcinoma; SD, standard deviation; EBUS, endobronchial ultrasound-guided needle aspiration; ES: ex-smoker; AS, active smoker; NLN, normal lymph node; LPH, lymphoma; M, mean; ME, median; MT, mediastinoscopy; WM, women; ND, no data; NS, never smoker; PET, positron emission tomography; SC, sarcoidosis or sarcomatoid reaction; TB, tuberculosis; CT, computed tomography.